← All candidates
Two insider buys in the last year — $144.6K in all.
24 filings on record.
AARDAardvark Therapeutics, Inc.
NasdaqGS · Healthcare · $109.86M
$5.55
+8.19% · Sep 14
Two insider buys in the last year — $144.6K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 4 buys● 2 sells◆ 10 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$109.86M
Float
11.0M
50% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Executive Officer
Lee Tien-Li
Bought $101.4K on Dec 11 — 7,000 sh @ $14.49, held direct, 0.5% of their stake.
0 of 1 position beat the S&P
Chief Financial Officer
Sun Nelson
Bought $48.4K on Sep 9 — 6,000 sh @ $8.07, held direct, 5.7% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
8 more transactions on Pro →Context
Wall St
$15.44 avg target
+178.3% vs today · 9 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
24 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice